The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 - 
ARRIVE -  Moderate Risk (ASCVD > 20%) 

<-> MACE
 + Increased bleeding 
 
ASCEND  - Diabetes 
 <-> MACE 
 ++ bleeding 
 
ASPREE  - 
Age > 70 

 <-> MACE 

+ bleeding 
+ mortality 

#Aspirin #VisualAbstract #ARRIVE #ASCEND #ASPREE #Management #EBM #Trials
Dr. Gerald Diaz @GeraldMD · 6 years ago
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Related images